Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors

PURPOSE: To describe patient characteristics and treatment patterns among early initiators of proprotein convertase subtilisin/kexin type nine inhibitors (PCSK9is) who initiated treatment within the first 6 months of market availability. PATIENTS AND METHODS: This retrospective cohort study used IQV...

Descripción completa

Detalles Bibliográficos
Autores principales: Hines, Dionne M, Rane, Pallavi, Patel, Jeetvan, Harrison, David J, Wade, Rolin L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292243/
https://www.ncbi.nlm.nih.gov/pubmed/30573963
http://dx.doi.org/10.2147/VHRM.S180496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292243/
https://www.ncbi.nlm.nih.gov/pubmed/30573963
http://dx.doi.org/10.2147/VHRM.S180496

Ejemplares similares